Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-6.72M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$8.78M
-
Number of sells
-
-31
Significant Holders of MIROMATRIX MED INC - COM (MIRO) as of Q4 2023
31 filings reported holding MIRO - MIROMATRIX MED INC - COM as of Q4 2023.
MIROMATRIX MED INC - COM (MIRO) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
.
Largest 10 shareholders include RAYMOND JAMES & ASSOCIATES (0 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (0 shares), US BANCORP \DE\ (0 shares), JPMORGAN CHASE & CO (0 shares), MORGAN STANLEY (0 shares), Mayo Clinic (0 shares), RTW INVESTMENTS, LP (0 shares), G2 Investment Partners Management LLC (0 shares), First Light Asset Management, LLC (0 shares), and HARBOUR INVESTMENTS, INC. (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.